Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inspire Medical Systems (INSP)
NYSE:INSP
RESEARCH TOOLSreports
Inspire Medical Systems (INSP) Stock Price & Analysis
633 Followers
INSP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$123.27 - $330.00
Previous Close$221.63
Volume297.52K
Average Volume (3M)479.25K
Market Cap
$6.76B
Enterprise Value$6.33B
Total Cash (Recent Filing)$460.38M
Total Debt (Recent Filing)$24.85M
Price to Earnings (P/E)-298.8
Beta1.31
Next Earnings
May 07, 2024EPS Estimate
-$0.65Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.74
Shares Outstanding29,585,104
10 Day Avg. Volume474,350
30 Day Avg. Volume479,255
Standard Deviation0.15
R-Squared0.23
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)11.98
Price to Sales (P/S)34.29
Price to Cash Flow (P/CF)99.30
P/FCF Ratio185.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue10.38
Enterprise Value/Gross Profit11.97
Enterprise Value/Ebitda-522.47
Forecast
1Y Price Target
$250.67Price Target Upside13.10% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14
Inspire Medical Systems News
Bulls Say, Bears Say
Bulls Say
Market PenetrationINSP holds the dominant share in the fast-growing, $10B US hypoglossal nerve stim market for OSA, with only 5% penetration, representing a vast market opportunity.
Product AdvantageINSP's minimally invasive, closed-loop neurostimulator maximizes patient comfort and compliance, outperforming other OSA treatments.
Stock ValuationAnalyst maintains a Buy rating with a price objective of 265.00 USD, indicating significant upside potential.
Bears Say
Financial PerformanceINSP expects a more pronounced sequential decline in 1Q24 sales than usual, with sales likely to be down mid- to high-teens percentage.
Market CompetitionPotential FDA approval of tirzepatide in OSA presents a competitive challenge for INSP.
Regulatory And Insurance ChangesThe recently announced policy change from UnitedHealth requiring Inspire patients to first try and fail oral appliance therapy introduces an additional headwind for INSP.
---
Ownership Overview
6.17% Insiders
53.45% Mutual Funds
12.71% Other Institutional Investors
27.68% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
INSP FAQ
What was Inspire Medical Systems’s price range in the past 12 months?
Inspire Medical Systems lowest stock price was $123.27 and its highest was $330.00 in the past 12 months.
What is Inspire Medical Systems’s market cap?
Currently, no data Available
When is Inspire Medical Systems’s upcoming earnings report date?
Inspire Medical Systems’s upcoming earnings report date is May 07, 2024 which is in 19 days.
How were Inspire Medical Systems’s earnings last quarter?
Inspire Medical Systems released its earnings results on Feb 06, 2024. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of -$0.053 by $0.543.
Is Inspire Medical Systems overvalued?
According to Wall Street analysts Inspire Medical Systems’s price is currently Undervalued.
Does Inspire Medical Systems pay dividends?
Inspire Medical Systems does not currently pay dividends.
What is Inspire Medical Systems’s EPS estimate?
Inspire Medical Systems’s EPS estimate is -$0.65.
How many shares outstanding does Inspire Medical Systems have?
Inspire Medical Systems has 30,297,312 shares outstanding.
What happened to Inspire Medical Systems’s price movement after its last earnings report?
Inspire Medical Systems reported an EPS of $0.49 in its last earnings report, beating expectations of -$0.053. Following the earnings report the stock price went down -10.549%.
Which hedge fund is a major shareholder of Inspire Medical Systems?
Among the largest hedge funds holding Inspire Medical Systems’s share is Farallon Capital Management, L.L.C.. It holds Inspire Medical Systems’s shares valued at 174M.
---
Inspire Medical Systems Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$250.67 (13.10% Upside)
$250.67 (13.10% Upside)
Blogger Sentiment
Bullish
INSP Sentiment 83%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 731.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $10.6M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 1.2%
Last 30 Days ▲ 1.2%
Last 30 Days ▲ 1.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-14.59%
12-Months-Change
Fundamentals
Return on Equity
-3.96%
Trailing 12-Months
Asset Growth
19.82%
Trailing 12-Months
Company Description
Inspire Medical Systems
Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. It offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.
---
INSP Company Deck
---
INSP Earnings Call
Q4 2024
0:00 / 0:00
---
INSP Revenue Breakdown
97.02% U.S.
2.98% Other
---
INSP Stock 12 Months Forecast
Average Price Target
$250.67
▲(13.10% Upside)
Technical Analysis
Best Analysts Covering INSP
1 Year
1 Year Success Rate
16/24 ratings generated profit
1 Year Average Return
+30.23%
reiterated a buy rating 2 months ago
Copying Adam Maeder's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +30.23% per trade.
---